170 results on '"Yue, Xuetian"'
Search Results
2. TIPE1 limits virus replication by disrupting PKM2/ HIF-1α/ glycolysis feedback loop
3. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling
4. ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury
5. Lipid accumulation-mediated histone hypoacetylation drives persistent NK cell dysfunction in anti-tumor immunity
6. Lipophagy-mediated cholesterol synthesis inhibition is required for the survival of hepatocellular carcinoma under glutamine deprivation
7. Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6
8. TIM-4 orchestrates mitochondrial homeostasis to promote lung cancer progression via ANXA2/PI3K/AKT/OPA1 axis
9. ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
10. Tim-4 alleviates acute hepatic injury by modulating homeostasis and function of NKT cells.
11. cccDNA Surrogate MC-HBV–Based Screen Identifies Cohesin Complex as a Novel HBV Restriction Factor
12. Urolithin A Hijacks ERK1/2‐ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity
13. Leukemia inhibitory factor drives glucose metabolic reprogramming to promote breast tumorigenesis
14. Beta‐Cell Tipe1 Orchestrates Insulin Secretion and Cell Proliferation by Promoting Gαs/cAMP Signaling via USP5
15. Lipid accumulation-mediated histone hypoacetylation drives persistent NK cell dysfunction in anti-tumor immunity
16. DNA sensor ABCF1 phase separates with cccDNA to inhibit HBV replication
17. Tumor suppressor p53 regulates intestinal type 2 immunity
18. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression
19. Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
20. Urolithin A Hijacks ERK1/2‐ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity.
21. Dynamic Hybrid Module-Driven NK Cell Stimulation and Release for Tumor Immunotherapy.
22. Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models
23. SREBF2–STARD4 axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasis
24. Tim-4 reprograms cholesterol metabolism to suppress antiviral innate immunity by disturbing the Insig1-SCAP interaction in macrophages
25. TIPE1 promotes liver regeneration by enhancing ROS‐FoxO1 axis mediated autophagy
26. NAD + salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity
27. Zinc Fingers and Homeoboxes 2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Represses Expression of Cyclins A and E
28. Additional file 2 of ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
29. Additional file 3 of ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
30. Tim-4 Reprograms Chol Esterol Metabolism to Suppress Antiviral Innate Immunity by Hampering Insig1-SCAP Interaction in Macrophages
31. Multi-Omics Analysis of Fatty Acid Metabolism in Thyroid Carcinoma
32. TIPE1 promotes liver regeneration by enhancing ROS‐FoxO1 axis mediated autophagy.
33. SREBF2–STARD4 axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasis.
34. Fatty Acid Metabolism as a Potential Therapeutic Target in Thyroid Carcinoma
35. ZHX2 inhibits SREBP1c‐mediated de novo lipogenesis in hepatocellular carcinoma via miR‐24‐3p
36. Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesis
37. EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling
38. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation
39. IL‐6 promotes metastasis of non‐small‐cell lung cancer by up‐regulating TIM‐4 via NF‐κB
40. Mapping cccDNA-Host Interactome Identifies Cohesin Complex as a Novel HBV Restriction Factor
41. Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
42. ZHX2 Restricts Hepatocellular Carcinoma by Suppressing Stem Cell-Like Traits Through KDM2A-Mediated H3K36 Demethylation
43. Research progress of tumor suppressor ZHX2
44. A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models
45. Author response: A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models
46. Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression
47. Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progression
48. Abstract 4406: Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression
49. Abstract 3417: The impact of p53 codon 72 SNP upon aging and longevity in mouse models
50. Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.